Cover Image
Market Research Report

Indian Cardiology Market Research and Forecast, 2018-2023

Published by Orion Market Research Pvt Ltd Product code 762907
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Indian Cardiology Market Research and Forecast, 2018-2023
Published: November 26, 2018 Content info:
Description

The Indian cardiology market is expected to grow at a significant growth rate during the forecast period. The report covers the Indian cardiology market in surgeries, drugs, and devices. The market is growing rapidly due to improving quality and operation standards in the country, variation in the lifestyle and rising aging population which is attracting the investors to invest across the country. Cardiology is basically dealing with the disorders of the heart as well as parts of the circulatory system. in addition, it deals with the diseases and abnormalities of the heart. There are certain risk and causes of cardiac problems which include high blood pressure and an increase in stress level at younger age obesity.

Cardiovascular devices market in India provides insights of latest device technologies in cardio rhythm; devices such as pacemakers, defibrillators, implantable cardioverter defibrillator, and cardio resynchronization therapy devices which are explained thoroughly in the report. This report also covers the market for cardiac surgery which includes circulatory support devices, interventional devices cardiac rhythm management devices, and vascular surgery devices. The key players in the domestic market of cardiology devices are Opto Circuits India, India Medtronic, and Boston Scientific India.

Cardiovascular devices in the Indian market are beneficial in technological advancements and low-cost medication which are dominated by domestic manufacturers. These manufacturers are playing a vital role in the Indian market to grow it substantially as a medical giant to attract investors. Innovation should progress from developing new products to gain an advantage over such products more efficiently with new innovative techniques and business models.

There are other factors also which are boosting the market growth of the Indian market such as R&D, growing cardiac healthcare units in the country and rise in domestic industries to compete with multinationals. Rising diagnostic centers across the globe, investment from the government and private players have bolstered the market growth. Moreover, rising medical tourism and increasing awareness among the society regarding the heart-related diseases are creating an opportunity for Indian cardiology market to grow. India being on a preference list is the perfect destination for the healthcare services, especially for cardiac surgery.

The key players of the Indian cardiology market include Johnson & Johnson India, Abbott Laboratories, Boston Scientific Corporation. Cardiac companies are constantly focusing on developing new techniques, low-cost devices for cutting down operation costs, R&D, merger & acquisition, innovation, and technological advancement. Kovai Medical Centre and Hospital in India provides continuum care for the prevention, treatment, recovery, and rehabilitation of the heart and vascular diseases.

Research methodology

The market study of the Indian Cardiology market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
  • Authenticate databases such as National Institute of Health, and cardiological Society of India.

The report is intended to cardiology drugs and devices manufacturer, healthcare providers, investing companies, government organization, for overall market analysis, and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market segmentation

Global battery market is segmented based on the following segments:

1. Indian Cardiology Market Research and Analysis, By Device Type

2. Indian Cardiology Market Research and Analysis, By Drugs Type

3. Indian Cardiology Market Research and Analysis, By Surgery Type

THE REPORT COVERS

  • Comprehensive research methodology of the Indian cardiology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Indian cardiology market.
  • Insights about market determinants which are stimulating the Indian cardiology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Table of Contents
Product Code: OMR2018431

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendation
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Increasing Lifestyle Oriented Diseases
    • 3.1.2. Rise in Healthcare and Insurance Coverage Rates
    • 3.1.3. Rising Regional Cardiology Players for Cardiology Drugs and Devices
    • 3.1.4. Technological Advancement and Innovation in Medical Procedures
  • 3.2. Restraints
    • 3.2.1. Limited Medical Infrastructure in Rural and Semi Urban Areas
    • 3.2.2. Skilled Manpower Is Required for Cardiac Surgeries
  • 3.3. Opportunities
    • 3.3.1. Rising Medical Tourism
    • 3.3.2. Government Initiatives for Increasing Cardiology Awareness

4. Market Segmentation

  • 4.1. Indian Cardiology Market by Cardiology Device Types
    • 4.1.1. Angioplasty
    • 4.1.2. Cardiovascular Stents
    • 4.1.3. Cardiovascular Catheters
    • 4.1.4. Cardiac Rhythm Management
    • 4.1.5. Cardiovascular Assistive Devices
  • 4.2. Indian Cardiology Market by Drugs Types
    • 4.2.1. Antithrombotic Drugs
    • 4.2.2. Antidyslipidemic Drugs
    • 4.2.3. Antihypertensive Drugs
    • 4.2.4. Anti-Stroke Drugs
  • 4.3. Indian Cardiology Market by Surgery Types
    • 4.3.1. Coronary Artery Bypass Grafting
    • 4.3.2. Transmyocardial Laser Revascularization
    • 4.3.3. Heart Valve Repair
    • 4.3.4. Arrhythmia Treatment
    • 4.3.5. Aneurysm Repair
    • 4.3.6. Heart Transplant

5. Competitive Landscape

  • 5.1. Key Strategies
  • 5.2. Key Company Analysis

6. Company Profiles

  • 6.1. Abbott Laboratories Inc.
  • 6.2. Bayer AG
  • 6.3. Boston Scientific Corporation
  • 6.4. Bristol-Myers Squibb Company
  • 6.5. Cook Medical Inc.
  • 6.6. CR Bard Inc.
  • 6.7. F. Hoffmann-La Roche Ltd.
  • 6.8. GE Healthcare
  • 6.9. Johnson and Johnson Inc.
  • 6.10. Medtronic PLC
  • 6.11. Meril Life Sciences Pvt. Ltd.
  • 6.12. Novartis International AG
  • 6.13. Pfizer Inc.
  • 6.14. Pfizer Inc.
  • 6.15. Pinnacle Biomed Pvt. Ltd.
  • 6.16. Sanofi SA
  • 6.17. St. Jude Medical, Inc.
  • 6.18. Takeda Pharmaceutical Company Limited
  • 6.19. Trivitron Healthcare Pvt. Ltd.
  • 6.20. Vascular Solutions, Inc.

List of Tables

  • TABLE # 1 INDIAN CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY DEVICE TYPES, 2017-2023($ MILLION)
  • TABLE # 2 INDIAN CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY DRUGS TYPES, 2017-2023($ MILLION)
  • TABLE # 3 INDIAN CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY SURGERY TYPES, 2017-2023($ MILLION)

List of Figures

  • FIGURE # 1 INDIAN CARDIOLOGY MARKET SHARE BY DEVICE TYPES, 2017 VS 2023 ($ MILLION)
  • FIGURE # 2 INDIAN CARDIOLOGY MARKET SHARE BY DRUGS TYPES, 2017 VS 2023 ($ MILLION)
  • FIGURE # 3 INDIAN CARDIOLOGY MARKET SHARE BY SURGERY TYPES, 2017 VS 2023 ($ MILLION)
Back to Top